Drug Trial Radar · NCT03980821
A Phase I Study of AZD4635 in Japanese Patients With Advanced Solid Malignancies
Last checked: Nov 19, 2026Latest source record: Dec 8, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
10
Actual
Start
Jul 4, 2019
Primary completion
Sep 7, 2020
Study completion Sep 7, 2020
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Jun 10, 2019
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- All sexes, from 20 years, up to 130 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase I, open-label study to assess the safety, tolerability, pharmacokinetics and anti-tumor activity of AZD4635 in Japanese patients with advanced solid malignancies. This study consists of 2 cohorts, Cohort1 and Cohort2. At least 3 or up to 6 evaluable Japanese patients with advanced solid malignancies will be enrolled in Cohort1 and 6 evaluable patients will be enrolled in Cohort2.
Conditions
- Advanced Solid Malignancies
Interventions
AZD4635Drug
AZD4635 taken orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- The incidence of Adverse event and SAETime frame: From the informed consent to 30 days post last dose
- The incidence of Dose-limiting toxicity (DLTs)Time frame: 25 days (Cycle0 and Cycle1)
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Chūōku, Japan
Research Site
Kashiwa, Japan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.